AMNEAL PHARMACEUTICALS, INC. (AMRX) vs Hims & Hers Health, Inc. (HIMS)
- AMNEAL PHARMACEUTICALS, INC. AMRX 19.18 −0.36%
- Hims & Hers Health, Inc. HIMS 28.07 −4.46%
AMNEAL PHARMACEUTICALS, INC. and Hims & Hers Health, Inc. are both Drug Manufacturers Specialty & Generic companies. Hims & Hers Health, Inc. is the larger, with a market value of $6.9B against $6.2B — 1.1× the size. Hims & Hers Health, Inc. has negative trailing earnings, so its P/E is not meaningful; AMNEAL PHARMACEUTICALS, INC. trades at 38.4×. Hims & Hers Health, Inc. grew revenue faster over the last twelve months: 28.0% against 9.28%. AMNEAL PHARMACEUTICALS, INC. has the higher net margin (5.05% vs −5.51%) and the higher return on invested capital (11.1% vs −11.4%). Across the 19 metrics below, Hims & Hers Health, Inc. leads on 11 and AMNEAL PHARMACEUTICALS, INC. on 8.
Valuation
Profitability
| Metric | AMRX | HIMS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 39.32% | 68.43% | 53.94% |
| Operating margin | 14.56% | (5.99%) | 0.00% |
| Net margin | 5.05% | (5.51%) | 0.00% |
| Free cash flow margin | (0.37%) | 3.22% | 0.00% |
| Return on equity | (395.84%) | (32.03%) | (0.40%) |
| Return on assets | 4.37% | (5.16%) | (3.32%) |
| Return on invested capital | 11.05% | (11.38%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack